Parallel CRISPR-Cas9 screens identify mechanisms of PLIN2 and lipid droplet regulation

Melissa A Roberts,Kirandeep K Deol,Alyssa J Mathiowetz,Mike Lange,Dara E Leto,Julian Stevenson,Sayed Hadi Hashemi,David W Morgens,Emilee Easter,Kartoosh Heydari,Mike A Nalls,Michael C Bassik,Martin Kampmann,Ron R Kopito,Faraz Faghri,James A Olzmann

DOI: https://doi.org/10.1016/j.devcel.2023.07.001

2023-09-25

Abstract:Despite the key roles of perilipin-2 (PLIN2) in governing lipid droplet (LD) metabolism, the mechanisms that regulate PLIN2 levels remain incompletely understood. Here, we leverage a set of genome-edited human PLIN2 reporter cell lines in a series of CRISPR-Cas9 loss-of-function screens, identifying genetic modifiers that influence PLIN2 expression and post-translational stability under different metabolic conditions and in different cell types. These regulators include canonical genes that control lipid metabolism as well as genes involved in ubiquitination, transcription, and mitochondrial function. We further demonstrate a role for the E3 ligase MARCH6 in regulating triacylglycerol biosynthesis, thereby influencing LD abundance and PLIN2 stability. Finally, our CRISPR screens and several published screens provide the foundation for CRISPRlipid (http://crisprlipid.org), an online data commons for lipid-related functional genomics data. Our study identifies mechanisms of PLIN2 and LD regulation and provides an extensive resource for the exploration of LD biology and lipid metabolism.